Investigation of Simvastatin in Secondary Progressive Multiple Sclerosis

NCT00647348 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

140

Enrollment

OTHER

Sponsor class

Conditions

Secondary Progressive Multiple Sclerosis

Interventions

DRUG: Simvastatin
DRUG: Placebo

Sponsor

Imperial College London